| Viviant Healthcare Of Bristol | |
| 250 Bellebrook Rd, Bristol, Tennessee 37620 | |
| (423) 968-4123 | |
| Name | Viviant Healthcare Of Bristol |
|---|---|
| Location | 250 Bellebrook Rd, Bristol, Tennessee |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 130 |
| Occupancy Rate | 42.85% |
| Medicare ID (CCN) | 445190 |
| Legal Business Name | Camb Op Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1013380534 |
| Organization Name | FRANKLIN CAMBRIDGE OPERATIONS, LLC |
| Doing Business As | THE CAMBRIDGE HOUSE |
| Address | 250 Belle Brook Rd, Bristol, TN 37620 |
| Phone Number | 423-968-4123 |
News Archive
An investigational treatment for an inherited form of Lou Gehrig's disease has passed an early phase clinical trial for safety, researchers at Washington University School of Medicine in St. Louis and Massachusetts General Hospital report.
One of the most challenging issues facing law enforcement today is handling encounters involving people with mental illness. Although the majority of people with mental illness do not commit criminal acts, around 1 in 5 will come into contact with the law as police officers are often the first to respond to incidents.
Tafamidis meglumine was approved in November 2011 for the treatment of transthyretin amyloidosis in adults. This rare disorder is caused by a defective gene and is associated with progressive nerve damage (neurological degeneration) that tafamidis is supposed to delay.
Nearly a third of all antibiotics prescribed for hospitalized children globally were intended to prevent potential infections rather than to treat disease, according to the results of a worldwide survey published in the Journal of the Pediatric Infectious Diseases Society.
› Verified 6 days ago
| NPI Number | 1023793312 |
| Organization Name | BELLEBROOK RD HEALTHCARE LLC |
| Address | 250 Bellebrook Rd, Bristol, TN 37620 |
| Phone Number | 423-968-4123 |
News Archive
An investigational treatment for an inherited form of Lou Gehrig's disease has passed an early phase clinical trial for safety, researchers at Washington University School of Medicine in St. Louis and Massachusetts General Hospital report.
One of the most challenging issues facing law enforcement today is handling encounters involving people with mental illness. Although the majority of people with mental illness do not commit criminal acts, around 1 in 5 will come into contact with the law as police officers are often the first to respond to incidents.
Tafamidis meglumine was approved in November 2011 for the treatment of transthyretin amyloidosis in adults. This rare disorder is caused by a defective gene and is associated with progressive nerve damage (neurological degeneration) that tafamidis is supposed to delay.
Nearly a third of all antibiotics prescribed for hospitalized children globally were intended to prevent potential infections rather than to treat disease, according to the results of a worldwide survey published in the Journal of the Pediatric Infectious Diseases Society.
› Verified 6 days ago
| NPI Number | 1124671888 |
| Organization Name | BRISTOL HEALTHCARE INVESTORS, LP |
| Address | 250 Belle Brook Rd, Bristol, TN 37620 |
| Phone Number | 423-968-4076 |
News Archive
An investigational treatment for an inherited form of Lou Gehrig's disease has passed an early phase clinical trial for safety, researchers at Washington University School of Medicine in St. Louis and Massachusetts General Hospital report.
One of the most challenging issues facing law enforcement today is handling encounters involving people with mental illness. Although the majority of people with mental illness do not commit criminal acts, around 1 in 5 will come into contact with the law as police officers are often the first to respond to incidents.
Tafamidis meglumine was approved in November 2011 for the treatment of transthyretin amyloidosis in adults. This rare disorder is caused by a defective gene and is associated with progressive nerve damage (neurological degeneration) that tafamidis is supposed to delay.
Nearly a third of all antibiotics prescribed for hospitalized children globally were intended to prevent potential infections rather than to treat disease, according to the results of a worldwide survey published in the Journal of the Pediatric Infectious Diseases Society.
› Verified 6 days ago
| NPI Number | 1164852968 |
| Organization Name | FRANKLIN HEALTHCARE, INC. |
| Address | 250 Belle Brook Rd, Bristol, TN 37620 |
| Phone Number | 423-968-4123 |
News Archive
An investigational treatment for an inherited form of Lou Gehrig's disease has passed an early phase clinical trial for safety, researchers at Washington University School of Medicine in St. Louis and Massachusetts General Hospital report.
One of the most challenging issues facing law enforcement today is handling encounters involving people with mental illness. Although the majority of people with mental illness do not commit criminal acts, around 1 in 5 will come into contact with the law as police officers are often the first to respond to incidents.
Tafamidis meglumine was approved in November 2011 for the treatment of transthyretin amyloidosis in adults. This rare disorder is caused by a defective gene and is associated with progressive nerve damage (neurological degeneration) that tafamidis is supposed to delay.
Nearly a third of all antibiotics prescribed for hospitalized children globally were intended to prevent potential infections rather than to treat disease, according to the results of a worldwide survey published in the Journal of the Pediatric Infectious Diseases Society.
› Verified 6 days ago
| NPI Number | 1235162405 |
| Organization Name | HP CAMBRIDGE HOUSE INC |
| Doing Business As | THE CAMBRIDGE HOUSE |
| Address | 250 Bellebrook Road, Bristol, TN 37620 |
| Phone Number | 423-968-4123 |
News Archive
An investigational treatment for an inherited form of Lou Gehrig's disease has passed an early phase clinical trial for safety, researchers at Washington University School of Medicine in St. Louis and Massachusetts General Hospital report.
One of the most challenging issues facing law enforcement today is handling encounters involving people with mental illness. Although the majority of people with mental illness do not commit criminal acts, around 1 in 5 will come into contact with the law as police officers are often the first to respond to incidents.
Tafamidis meglumine was approved in November 2011 for the treatment of transthyretin amyloidosis in adults. This rare disorder is caused by a defective gene and is associated with progressive nerve damage (neurological degeneration) that tafamidis is supposed to delay.
Nearly a third of all antibiotics prescribed for hospitalized children globally were intended to prevent potential infections rather than to treat disease, according to the results of a worldwide survey published in the Journal of the Pediatric Infectious Diseases Society.
› Verified 6 days ago
| NPI Number | 1235744848 |
| Organization Name | CAMB OP LLC |
| Doing Business As | VIVIANT HEALTHCARE OF BRISTOL |
| Address | 250 Belle Brook Rd, Bristol, TN 37620 |
| Phone Number | 423-968-4123 |
News Archive
An investigational treatment for an inherited form of Lou Gehrig's disease has passed an early phase clinical trial for safety, researchers at Washington University School of Medicine in St. Louis and Massachusetts General Hospital report.
One of the most challenging issues facing law enforcement today is handling encounters involving people with mental illness. Although the majority of people with mental illness do not commit criminal acts, around 1 in 5 will come into contact with the law as police officers are often the first to respond to incidents.
Tafamidis meglumine was approved in November 2011 for the treatment of transthyretin amyloidosis in adults. This rare disorder is caused by a defective gene and is associated with progressive nerve damage (neurological degeneration) that tafamidis is supposed to delay.
Nearly a third of all antibiotics prescribed for hospitalized children globally were intended to prevent potential infections rather than to treat disease, according to the results of a worldwide survey published in the Journal of the Pediatric Infectious Diseases Society.
› Verified 6 days ago
| NPI Number | 1598150211 |
| Organization Name | CAMBRIDGE CARE CENTER LLC |
| Doing Business As | CAMBRIDGE CARE CENTER |
| Address | 250 Belle Brook Rd, Bristol, TN 37620 |
| Phone Number | 423-968-4123 |
News Archive
An investigational treatment for an inherited form of Lou Gehrig's disease has passed an early phase clinical trial for safety, researchers at Washington University School of Medicine in St. Louis and Massachusetts General Hospital report.
One of the most challenging issues facing law enforcement today is handling encounters involving people with mental illness. Although the majority of people with mental illness do not commit criminal acts, around 1 in 5 will come into contact with the law as police officers are often the first to respond to incidents.
Tafamidis meglumine was approved in November 2011 for the treatment of transthyretin amyloidosis in adults. This rare disorder is caused by a defective gene and is associated with progressive nerve damage (neurological degeneration) that tafamidis is supposed to delay.
Nearly a third of all antibiotics prescribed for hospitalized children globally were intended to prevent potential infections rather than to treat disease, according to the results of a worldwide survey published in the Journal of the Pediatric Infectious Diseases Society.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
An investigational treatment for an inherited form of Lou Gehrig's disease has passed an early phase clinical trial for safety, researchers at Washington University School of Medicine in St. Louis and Massachusetts General Hospital report.
One of the most challenging issues facing law enforcement today is handling encounters involving people with mental illness. Although the majority of people with mental illness do not commit criminal acts, around 1 in 5 will come into contact with the law as police officers are often the first to respond to incidents.
Tafamidis meglumine was approved in November 2011 for the treatment of transthyretin amyloidosis in adults. This rare disorder is caused by a defective gene and is associated with progressive nerve damage (neurological degeneration) that tafamidis is supposed to delay.
Nearly a third of all antibiotics prescribed for hospitalized children globally were intended to prevent potential infections rather than to treat disease, according to the results of a worldwide survey published in the Journal of the Pediatric Infectious Diseases Society.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 4 |
| Total Amount of Fines in Dollars | $71423 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 4 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 18.9 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 8.4 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 38.46 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.39 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.14 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 8.38 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 16.15 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 96.98 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 21.17 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 24.68 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 4.46 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.5 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 57.24 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 97.89 | 82.93 |
News Archive
An investigational treatment for an inherited form of Lou Gehrig's disease has passed an early phase clinical trial for safety, researchers at Washington University School of Medicine in St. Louis and Massachusetts General Hospital report.
One of the most challenging issues facing law enforcement today is handling encounters involving people with mental illness. Although the majority of people with mental illness do not commit criminal acts, around 1 in 5 will come into contact with the law as police officers are often the first to respond to incidents.
Tafamidis meglumine was approved in November 2011 for the treatment of transthyretin amyloidosis in adults. This rare disorder is caused by a defective gene and is associated with progressive nerve damage (neurological degeneration) that tafamidis is supposed to delay.
Nearly a third of all antibiotics prescribed for hospitalized children globally were intended to prevent potential infections rather than to treat disease, according to the results of a worldwide survey published in the Journal of the Pediatric Infectious Diseases Society.
› Verified 6 days ago
Viviant Healthcare Of Bristol Location: 250 Bellebrook Rd, Bristol, Tennessee 37620 Phone: (423) 968-4123 |